人类有望在两三内治愈癌症【DOC精选】.docVIP

人类能否在两三年内治愈癌症？ How one company is using artificial intelligence to develop a cure for cancer Could we be just two or three years away from curing cancer? Niven Narain, the president of Berg, a small Boston-based biotech firm, says that may very well be the case. 我们是否真的在两三年之后，就能实现治愈癌症的愿景？波士顿小型生物科技公司Berg的总裁尼文?纳雷因表示，可能真是这样。 With funding from billionaire real-estate tycoon Carl Berg as well as from Mitch Gray, Narain, a medical doctor by training, and his small army of scientists, technicians, and programmers, have spent the last six years perfecting and testing an artificial intelligence platform that he believes could soon crack the cancer code, in addition to discovering valuable information about a variety of other terrible diseases, including Parkinson’s. 凭借亿万富翁、房地产业大鳄卡尔?伯格和米奇?格雷提供的资金，纳雷因和他带领的科学家、技术人员和编程人员团队耗时6年，完善并测试了一个人工智能平台，纳雷因认为，这个平台可能很快就会解开癌症的密码，同时为治疗包括帕金森症在内的一系列严重疾病提供有价值的信息。 Thanks to partnerships formed with universities, hospitals, and even the U.S. Department of Defense, Berg and its supercomputers have been able to analyze thousands of patient records and tissue samples to find possible new drug targets and biomarkers. 凭借着跟多所大学、医院甚至美国国防部建立的合作关系，伯格公司及其超级计算机系统已经分析了成千上万的病历和组织样本，以找到有可能全新的药物靶标和生物标志。 All this data crunching has led to the development of Berg’s first drug, BPM 31510, which is in clinical trials. The drug acts by essentially reprogramming the metabolism of cancer cells, re-teaching them to undergo apoptosis, or cell death. In doing so, the cancer cells die off naturally, without the need for harmful and expensive chemotherapy. 经过庞大的数据计算，伯格公司开发出第一款新药——BPM 31510，目前该药已经进入临床测试阶段。它可以重组癌细胞的新陈代谢，重新教会癌细胞如何死亡。在这个过程中，癌细胞就会自然死亡，使患者不必经历对身体伤害极大又十分昂贵的化疗过程。 So far, Berg has concentrated most of its resources on prostate cancer, given the large amount of data available on the disease. But thanks to recently announced partnerships, the firm is now building a new modeltargeting pancreatic cancer, which is one of the deadliest forms of cancers with a survivorship r